Gentamicin is added after host cells have been exposed to Neisseria meningitidis. The antibiotic eliminates organisms remaining outside the cells, while bacteria that have entered host cells can subsequently be released and quantified. The resulting colony count therefore provides a readout of viable intracellular meningococci under the tested host-cell and bacterial conditions.
The invasion assay primarily quantifies bacteria that remain recoverable after extracellular organisms have been eliminated, so its strongest readout concerns internalization and intracellular survival. Attachment contributes to the opportunity for entry but is not necessarily measured independently. Comparing assay conditions or bacterial variants can help identify factors associated with adhesion, entry, or both.
Bacterial strain, host-cell condition, and targeted bacterial genetic mutations can all influence the number of organisms recovered. These comparisons help reveal whether particular meningococcal features or cellular environments favor adhesion, internalization, or survival after entry. Interpreting results requires keeping the comparison focused on the specific strain, host condition, or mutation being evaluated.
The workflow begins by culturing epithelial or endothelial host cells and exposing them to meningococci. After the interaction period, gentamicin is applied to remove extracellular bacteria. Host-cell-associated intracellular organisms are then released, and the recovered bacteria are quantified by colony counting. Results are compared across strains, mutants, or host-cell conditions.
Colony counting reports the number of viable meningococci recovered from within the host-cell system after extracellular bacteria have been removed. Higher or lower counts indicate differences in the combined outcome of bacterial entry and survival under the selected conditions. The measurement is especially useful for comparing strains, genetic mutants, or altered host-cell environments.
This method is useful when investigators need to examine meningococcal pathogenesis at the host-cell interface. It supports studies of host–pathogen interactions and helps evaluate bacterial factors that contribute to invasive disease. The same comparison framework can also be applied when assessing potential antimicrobial or preventive strategies that alter bacterial entry or intracellular recovery.